GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (XSWX:CURN) » Definitions » Change In Other Working Capital

Curatis Holding AG (XSWX:CURN) Change In Other Working Capital : CHF-0.08 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Curatis Holding AG Change In Other Working Capital?

Curatis Holding AG's Change In Other Working Capital for the quarter that ended in Jun. 2024 was CHF-0.08 Mil. It means Curatis Holding AG's Other Working Capital declined by CHF0.08 Mil from Dec. 2023 to Jun. 2024 .

Curatis Holding AG's Change In Other Working Capital for the fiscal year that ended in Dec. 2023 was CHF0.00 Mil. It means Curatis Holding AG's Other Working Capital stayed the same from Dec. 2022 to Dec. 2023 .


Curatis Holding AG Change In Other Working Capital Historical Data

The historical data trend for Curatis Holding AG's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG Change In Other Working Capital Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Change In Other Working Capital
- - -

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Change In Other Working Capital Get a 7-Day Free Trial - - - - -0.08

Curatis Holding AG Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-0.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Weierweg 7, Liestal, CHE, CH-4410
Curatis Holding AG is a specialty pharmaceutical company based in Switzerland. It focus on the acquisition, development and commercialisation of medicines for the prevention, diagnosis and treatment of rare and specialty care diseases. Curatis is engaged in two business areas: Distribution business for orphan disease and specialty care medicines and Development business for orphan and specialty care disease medicines. Its product include Aggrastat (Tirofiban), AmbiFul (Fulvestrant), Brinavess (Vernakalant), Coldistop, Cuprior (Trientin), Cyanokit (Hydroxocobalamin), etc.